SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-015808
Filing Date
2022-11-01
Accepted
2022-11-01 16:18:43
Documents
99
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20220930x10q.htm   iXBRL 10-Q 2720770
2 EX-31.1 bpmc-20220930xex31d1.htm EX-31.1 11338
3 EX-31.2 bpmc-20220930xex31d2.htm EX-31.2 11409
4 EX-32.1 bpmc-20220930xex32d1.htm EX-32.1 10665
  Complete submission text file 0001558370-22-015808.txt   10278137

Data Files

Seq Description Document Type Size
5 EX-101.SCH bpmc-20220930.xsd EX-101.SCH 83261
6 EX-101.CAL bpmc-20220930_cal.xml EX-101.CAL 63826
7 EX-101.DEF bpmc-20220930_def.xml EX-101.DEF 323117
8 EX-101.LAB bpmc-20220930_lab.xml EX-101.LAB 592535
9 EX-101.PRE bpmc-20220930_pre.xml EX-101.PRE 535167
93 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20220930x10q_htm.xml XML 1837840
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 221350492
SIC: 2834 Pharmaceutical Preparations